Novavax price target raised to $14.86 by analyst
An analyst raised Novavax’s 12-month stock price target to $14.86, implying 35% upside, per FactSet data referenced in the feed.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
An analyst raised Novavax’s 12-month stock price target to $14.86, implying 35% upside, per FactSet data referenced in the feed.